Georgios Papadakis

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


40 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 |
Effects of empagliflozin on reproductive system in men without diabetes.
Kosinski C., Papadakis G.E., Salamin O., Kuuranne T., Nicoli R., Pitteloud N., Zanchi A., 2024/06/14. Scientific reports, 14 (1) p. 13802. Peer-reviewed.
 
Section VI: Endocrinology and the life span - Chapter 23: Physiology and Disorders of puberty
Papadakis Georgios E., Pitteloud Nelly, 2024/04/03. pp. 1001-1120 dans Williams Textbook of Endocrinology chap. 23, Elsevier.
 
Endocrinologie: ce qui a changé en 2023 [Endocrinology: what's new in 2023]
Ameti A., Chouchane K., Fontana E., Papadakis G.E., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 36-41. Peer-reviewed.
 
Impact of Cushing's syndrome on the gonadotrope axis and testicular functions in men.
Papadakis G.E., de Kalbermatten B., Dormoy A., Salenave S., Trabado S., Vieira-Pinto O., Richa C., Kamenicky P., Chanson P., Maione L. et al., 2023/12/04. Human reproduction, 38 (12) pp. 2350-2361. Peer-reviewed.
The Enhanced Recovery After Surgery protocol for the perioperative management of pituitary neuroendocrine tumors/pituitary adenomas.
Cossu G., Belouaer A., Kloeckner J., Caliman C., Agri F., Daniel R.T., Gaudet J.G., Papadakis G.E., Messerer M., 2023/12. Neurosurgical focus, 55 (6) pp. E9. Peer-reviewed.
Implementation of the Enhanced Recovery After Surgery (ERAS®) program in neurosurgery.
Belouaer A., Cossu G., Papadakis G.E., Gaudet J.G., Perez M.H., Chanez V., Boegli Y., Mury C., Peters D., Addor V. et al., 2023/11. Acta neurochirurgica, 165 (11) pp. 3137-3145. Peer-reviewed.
 
5 minutes pour apprendre. Des os fragiles [Brittle bones]
Fargeat M., Blondet F., Papadakis G.E., 2023/10/11. Revue medicale suisse, 19 (845) pp. 1852-1853. Peer-reviewed.
Defective jagged-1 signaling affects GnRH development and contributes to congenital hypogonadotropic hypogonadism.
Cotellessa L., Marelli F., Duminuco P., Adamo M., Papadakis G.E., Bartoloni L., Sato N., Lang-Muritano M., Troendle A., Dhillo W.S. et al., 2023/03/08. JCI insight, 8 (5) pp. e161998. Peer-reviewed.
NOS1 mutations cause hypogonadotropic hypogonadism with sensory and cognitive deficits that can be reversed in infantile mice.
Chachlaki K., Messina A., Delli V., Leysen V., Maurnyi C., Huber C., Ternier G., Skrapits K., Papadakis G., Shruti S. et al., 2022/10/05. Science translational medicine, 14 (665) pp. eabh2369. Peer-reviewed.
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas.
Cossu G., Turin-Huet V., Garvayo Navarro M., Papadakis G., Daniel R.T., Dunet V., Messerer M., 2022/06. Pituitary, 25 (3) pp. 468-473. Peer-reviewed.
Navigating Disrupted Puberty: Development and Evaluation of a Mobile-Health Transition Passport for Klinefelter Syndrome.
Dwyer A.A., Héritier V., Llahana S., Edelman L., Papadakis G.E., Vaucher L., Pitteloud N., Hauschild M., 2022. Frontiers in endocrinology, 13 p. 909830. Peer-reviewed.
Potential Association Between Anabolic Androgenic Steroid Abuse and Pituitary Apoplexy: A Case Report.
Andriuskeviciute A., Cossu G., Ameti A., Papadakis G., Daniel R.T., Dunet V., Messerer M., 2022. Frontiers in endocrinology, 13 p. 890853. Peer-reviewed.
Prise en charge des adénomes hypophysaires
Papadakis Georgios E., Marino Laura, Rouiller Nathalie, Pitteloud Nelly, 2021/11/23. Forum Médical Suisse ‒ Swiss Medical Forum.
Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.
Gonzalez Rodriguez E., Marques-Vidal P., Aubry-Rozier B., Papadakis G., Preisig M., Kuehner C., Vollenweider P., Waeber G., Hans D., Lamy O., 2021/11. Calcified tissue international, 109 (5) pp. 499-509. Peer-reviewed.
Compromised Volumetric Bone Density and Microarchitecture in Men With Congenital Hypogonadotropic Hypogonadism.
Ostertag A., Papadakis G.E., Collet C., Trabado S., Maione L., Pitteloud N., Bouligand J., De Vernejoul M.C., Cohen-Solal M., Young J., 2021/08/18. The Journal of clinical endocrinology and metabolism, 106 (9) pp. e3312-e3326. Peer-reviewed.
 
Pathogenic mosaic variants in congenital hypogonadotropic hypogonadism.
Acierno J.S., Xu C., Papadakis G.E., Niederländer N.J., Rademaker J.D., Meylan J., Messina A., Kolesinska Z., Quinton R., Lang-Muritano M. et al., 2020/11. Genetics in medicine, 22 (11) pp. 1759-1767. Peer-reviewed.
Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations.
Papadakis G.E., Dumont A., Bouligand J., Chasseloup F., Raggi A., Catteau-Jonard S., Boute-Benejean O., Pitteloud N., Young J., Dewailly D., 2020/04/28. Human reproduction, 35 (4) pp. 939-949. Peer-reviewed.
Congenital hypogonadotropic hypogonadism/Kallmann syndrome is associated with statural gain in both men and women: a monocentric study.
Maione L., Pala G., Bouvattier C., Trabado S., Papadakis G., Chanson P., Bouligand J., Pitteloud N., Dwyer A.A., Maghnie M. et al., 2020/02. European journal of endocrinology, 182 (2) p. 185. Peer-reviewed.
 
Hypothalamic Disorders During Ovulation, Pregnancy, and Lactation
Papadakis Georgios E., Xu Cheng, Pitteloud Nelly, 2020. pp. 217-240 dans Maternal-Fetal and Neonatal Endocrinology, Elsevier.
 
Normal Endocrine Physiology of Hypothalamic Hormones During Ovulation, Pregnancy, and Lactation
Xu Cheng, Papadakis Georgios E., Pitteloud Nelly, 2020. pp. 7-14 dans Maternal-Fetal and Neonatal Endocrinology, Elsevier.
 
Une hypokaliémie sévère et réfractaire
Basbous Mohamed, Papadakis Georgios, Lamine Faiza, Tagan Damien, 2019/09/25. Forum Médical Suisse ‒ Swiss Medical Forum.
The Metabolic Benefits of Menopausal Hormone Therapy Are Not Mediated by Improved Nutritional Habits. The OsteoLaus Cohort.
Papadakis G.E., Hans D., Gonzalez Rodriguez E., Vollenweider P., Waeber G., Marques-Vidal P., Lamy O., 2019/08/16. Nutrients, 11 (8). Peer-reviewed.
Defective AMH signaling disrupts GnRH neuron development and function and contributes to hypogonadotropic hypogonadism.
Malone S.A., Papadakis G.E., Messina A., Mimouni NEH, Trova S., Imbernon M., Allet C., Cimino I., Acierno J., Cassatella D. et al., 2019/07/10. eLife, 8. Peer-reviewed.
 
Effects of menopausal hormone therapy on bone and body composition
Papadakis Georgios E, Lamy Olivier, 2019/05. Osteologie, 28 (02) pp. 122-130.
 
Traitement hormonal de la ménopause : effets osseux et sur la composition corporelle [Menopausal hormone therapy. Effects on bone and body composition]
Papadakis G., Gonzalez Rodriguez E., Marques-Vidal P., Hans D., Vollenweider P., Waeber G., Lamy O., 2019/04/17. Revue medicale suisse, 15 (647) pp. 836-839. Peer-reviewed.
Clinical Management of Congenital Hypogonadotropic Hypogonadism.
Young J., Xu C., Papadakis G.E., Acierno J.S., Maione L., Hietamäki J., Raivio T., Pitteloud N., 2019/04/01. Endocrine reviews, 40 (2) pp. 669-710. Peer-reviewed.
Response to Letter to the Editor: "Menopausal Hormone Therapy Is Associated With Reduced and Total Visceral Adiposity: The OsteoLaus Cohort".
Papadakis G.E., Lamy O., 2018/11/01. The Journal of clinical endocrinology and metabolism, 103 (11) pp. 4035-4036. Peer-reviewed.
Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants.
Xu C., Cassatella D., van der Sloot A.M., Quinton R., Hauschild M., De Geyter C., Flück C., Feller K., Bartholdi D., Nemeth A. et al., 2018/08. Genetics in medicine, 20 (8) pp. 872-881. Peer-reviewed.
Menopausal Hormone Therapy Is Associated With Reduced Total and Visceral Adiposity: The OsteoLaus Cohort.
Papadakis G.E., Hans D., Rodriguez E.G., Vollenweider P., Waeber G., Marques-Vidal P., Lamy O., 2018/05/01. The Journal of clinical endocrinology and metabolism, 103 (5) pp. 1948-1957. Peer-reviewed.
The Bethesda System for Reporting Thyroid Cytopathology Explained for Practitioners: Frequently Asked Questions.
Bongiovanni M., Papadakis G.E., Rouiller N., Marino L., Lamine F., Bisig B., Ziadi S., Sykiotis G.P., 2018/05. Thyroid, 28 (5) pp. 556-565. Peer-reviewed.
Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures.
Cassatella D., Howard S.R., Acierno J.S., Xu C., Papadakis G.E., Santoni F.A., Dwyer A.A., Santini S., Sykiotis G.P., Chambion C. et al., 2018/04. European journal of endocrinology, 178 (4) pp. 377-388. Peer-reviewed.
Uptake of 99mTc-MIBI by Sclerosing Pneumocytoma Raising a False Suspicion of Metastasis From Medullary Thyroid Carcinoma.
Papadakis G.E., Tabotta F., Levotanec I., Gonzalez M., Prior J.O., La Rosa S., Sykiotis G.P., 2018/04/01. Journal of the Endocrine Society, 2 (4) pp. 386-390. Peer-reviewed.
Prurit-disciplinaire
Schneider Alexandra, Moschouri Eleni, Fraga Christinet Montserrat, Sciarra Amedeo, Sempoux Christine, Papadakis Georgios, Sykiotis Gerasimos, Sartori Claudio, Duss François-Regis, 2018/02/14. Forum Médical Suisse ‒ Swiss Medical Forum, 18 (07).
Rapid Remission of Graves' Hyperthyroidism Without Thionamides Under Immunosuppressive Treatment for Concomitant Autoimmune Hepatitis.
Papadakis G.E., Lamine F., Chtioui H., Moschouri E., Christinet M.F., Marino L., Favre L., Sciarra A., Sempoux C., Schneider A. et al., 2018/02. Thyroid, 28 (2) pp. 276-278. Peer-reviewed.
DCC/NTN1 complex mutations in patients with congenital hypogonadotropic hypogonadism impair GnRH neuron development.
Bouilly J., Messina A., Papadakis G., Cassatella D., Xu C., Acierno J.S., Tata B., Sykiotis G., Santini S., Sidis Y. et al., 2018/01/15. Human molecular genetics, 27 (2) pp. 359-372. Peer-reviewed.
Nodules et carcinomes thyroïdiens
Rouiller N., Papadakis G., Bongiovanni M, Sykiotis G., 2017/11/22. Swiss Medical Forum = Forum Médical Suisse, 47 pp. 1040-1045. Peer-reviewed.
Patients' preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment.
Hiligsmann M., Dellaert B.G., Dirksen C.D., Watson V., Bours S., Goemaere S., Reginster J.Y., Roux C., McGowan B., Silke C. et al., 2017/04/06. Rheumatology, 56 (7) pp. 1167-1176. Peer-reviewed.
The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
Papadakis G., Hans D., Gonzalez-Rodriguez E., Vollenweider P., Waeber G., Marques-Vidal P.M., Lamy O., 2016/12. The Journal of clinical endocrinology and metabolism, 101 (12) pp. 5004-5011. Peer-reviewed.
Are Patients' Preferences Transferable Between Countries? A Cross-European Discrete-Choice Experiment to Elicit Patients' Preferences for Osteoporosis Drug Treatment.
Hiligsmann M, Dellaert B, Dirksen C, Van dW, Watson V, Goemaere S, Reginster JY, Bours S, Roux C, McGowan B et al., 2014/11. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
An unusual case of hypercortisolism with multiple weight-bearing bone fractures.
Papadakis G., Uebelhart B., Goumaz M., Zawadynski S., Rizzoli R., 2013/09. Clinical cases in mineral and bone metabolism, 10 (3) pp. 213-217. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University